Dark | Light
# Karuna Therapeutics, Inc. Common Stock (KRTX)

Bristol-Myers Squibb is reportedly acquiring Karuna Therapeutics for $14 billion, signaling strong interest in the schizophrenia drug KarXT and the growing neurology market. This move follows a similar acquisition of Cerevel Therapeutics by AbbVie, highlighting a trend of major pharmaceutical companies investing in neurological treatments.

### About Karuna Therapeutics, Inc. Common Stock
Karuna Therapeutics, Inc. Common Stock (KRTX) is a publicly traded biotechnology company.  
Karuna Therapeutics, Inc. Common Stock uses the ticker $KRTX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Karuna Therapeutics, Inc. Common Stock (KRTX) market dominance near a 52-week low at [-------].
- Karuna Therapeutics, Inc. Common Stock (KRTX) engagements hit [----] which is 226% higher than it's daily average.
- Karuna Therapeutics, Inc. Common Stock (KRTX) social dominance is up 168.57% from the previous week.
- Karuna Therapeutics, Inc. Common Stock (KRTX) Galaxy Score™ is up 180% from the previous week.
- Karuna Therapeutics, Inc. Common Stock (KRTX) engagements is up 63.99% from the previous week.
- Karuna Therapeutics, Inc. Common Stock (KRTX) posts created is up 58.05% from the previous [--] months.

### Price: $329.80
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/close.tsv)  
KRTX is trading at its 1-year high and low, indicating price consolidation. The recent surge in social media sentiment and engagements, coupled with 100% positive sentiment, suggests a potential for price appreciation if this trend continues.  

1-Year High: $329.80 on 2025-02-15  
1-Year Low: $329.80 on 2025-02-15  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/alt_rank.tsv)  
Karuna Therapeutics, Inc. Common Stock (KRTX) is currently AltRank #1,225 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +258  
[--] Month: [-----] +175  
[--] Months: [-----] +155  
[--] Year: [-----] [----]  
1-Year High: [-----] on 2026-01-30  
1-Year Low: [--] on 2025-07-06  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +27  
[--] Month: [--] +17  
[--] Months: [--] +2  
[--] Year: [--] +12  
1-Year High: [--] on 2025-03-03  
1-Year Low: [--] on 2025-06-07  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [-----]  
[--] Week: [------] +64%  
[--] Month: [------] -17%  
[--] Months: [-------] -25%  
[--] Year: [---------] -44%  
1-Year High: [------] on 2025-08-12  
1-Year Low: [---] on 2025-12-07  

Engagements by network (24h):
Reddit: [--]
X: [------]
News: [--]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] -16%  
[--] Month: [---] +44%  
[--] Months: [---] -5.30%  
[--] Year: [---] -41%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-12-07  

Mentions by network (24h):
Reddit: [--]
X: [--]
News: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Karuna Therapeutics, Inc. Common Stock (KRTX) in the last [--] hours which is up 38% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] -27%  
[--] Month: [--] +56%  
[--] Months: [---] -22%  
[--] Year: [---] -32%  
1-Year High: [--] on 2025-06-28  
1-Year Low: [--] on 2025-12-15  

The most influential creators that mention Karuna Therapeutics, Inc. Common Stock in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [-----]     | [--]     | [---]         |
| [@ParadiseTraderr](/creator/twitter/ParadiseTraderr) | [--]    | [---]       | [--]     | [--]          |
| [@SMALLCAPSAXIS](/creator/twitter/SMALLCAPSAXIS)     | [--]    | [---]       | [--]     | [--]          |

[View More](/list/creators/$krtx/100)
  
  
### Sentiment: 100%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/sentiment.tsv)  
Current Value: 100%  
Daily Average: 96%  
[--] Week: 100% no change  
[--] Month: 93% -7%  
[--] Months: 93% -7%  
[--] Year: 93% -7%  
1-Year High: 100% on 2025-02-15  
1-Year Low: 33% on 2025-04-23  

Most Supportive Themes:
- Portfolio Mentions: (75%) Karuna Therapeutics, Inc. Common Stock (KRTX) is frequently included in investor portfolios and watchlist updates, indicating its relevance in investment strategies.
- Biotech and Healthcare Focus: (25%) Discussions surrounding KRTX are concentrated within the biotechnology and healthcare sectors, highlighting its specific industry relevance.
  
Most Critical Themes:
  
  
  
### Social Dominance: 0.00186%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/social_dominance.tsv)  
Current Value: 0.00186%  
Daily Average: 0.00264%  
[--] Week: 0.00188% +0.00118%  
[--] Month: 0.0017% -0.00030000000000000014%  
[--] Months: 0.0017% -0.0014%  
[--] Year: 0.0017% -0.0017%  
1-Year High: 0.013% on 2025-02-19  
1-Year Low: 0.0004% on 2025-12-13  
  
  
### Market Dominance: 0.014%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/market_dominance.tsv)  
Current Value: 0.014%  
Daily Average: 0%  
1-Year High: 0.02% on 2025-04-08  
1-Year Low: 0.014% on 2026-02-02  

### Top Karuna Therapeutics, Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"LT position into [----] Part [--] # [--] Portfolio Pick Buyouts $RNA $NARI $BPMC $MYOV $IMGN $KRTX $HZNP $PRVB $ISEE $BLU $CTIC $FSTX $ICVX $LVGO $STML $JUNO $CMRX $RLYP $ITCI $KVUE Tech positions in order- $AMZN $TSLA $SOFI $COIN $GOOG $NVDA $AMD $RBRK $META $NFLX $UBER $MSFT $AVGO $ZS $MELI $IREN $NBIS Top Biotech positions: $VKTX $CYTK $BBIO $TMDX $MDGL $HROW $SLNO $IMNM $GPCR $OCUL $CRVS https://twitter.com/i/web/status/2002067407834374356 https://twitter.com/i/web/status/2002067407834374356"  
[X Link](https://x.com/Pharmdca/status/2002067407834374356) [@Pharmdca](/creator/x/Pharmdca) 2025-12-19T17:24Z 108.6K followers, 56.1K engagements


"Bristol-Myers Squibb $BMY compra Karuna Therapeutics $KRTX por 14B$ esta empresa tiene un medicamento que est apunto de salir al mercado KarXT que sirve para tratar a pacientes con esquizofrenia. Parece que las grandes farmas ven con buenos ojos el crecimiento futuro de los medicamentos relacionados con la neurologa para tratar enfermedades como el prkinson o la propia esquizofrenia ya que la compra de Cerevel Therapeutics por parte de $ABBV de hace tan solo unas semanas busca un objetivo similar. https://twitter.com/i/web/status/1738485579422011854"  
[X Link](https://x.com/ProfesorDiv/status/1738485579422011854) [@ProfesorDiv](/creator/x/ProfesorDiv) 2023-12-23T09:03Z 32.6K followers, 21.2K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Karuna Therapeutics, Inc. Common Stock (KRTX)

Bristol-Myers Squibb is reportedly acquiring Karuna Therapeutics for $14 billion, signaling strong interest in the schizophrenia drug KarXT and the growing neurology market. This move follows a similar acquisition of Cerevel Therapeutics by AbbVie, highlighting a trend of major pharmaceutical companies investing in neurological treatments.

About Karuna Therapeutics, Inc. Common Stock

Karuna Therapeutics, Inc. Common Stock (KRTX) is a publicly traded biotechnology company.
Karuna Therapeutics, Inc. Common Stock uses the ticker $KRTX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Karuna Therapeutics, Inc. Common Stock (KRTX) market dominance near a 52-week low at [-------].
  • Karuna Therapeutics, Inc. Common Stock (KRTX) engagements hit [----] which is 226% higher than it's daily average.
  • Karuna Therapeutics, Inc. Common Stock (KRTX) social dominance is up 168.57% from the previous week.
  • Karuna Therapeutics, Inc. Common Stock (KRTX) Galaxy Score™ is up 180% from the previous week.
  • Karuna Therapeutics, Inc. Common Stock (KRTX) engagements is up 63.99% from the previous week.
  • Karuna Therapeutics, Inc. Common Stock (KRTX) posts created is up 58.05% from the previous [--] months.

Price: $329.80

Price Line Chart
Price 24-Hour Time-Series Raw Data
KRTX is trading at its 1-year high and low, indicating price consolidation. The recent surge in social media sentiment and engagements, coupled with 100% positive sentiment, suggests a potential for price appreciation if this trend continues.

1-Year High: $329.80 on 2025-02-15
1-Year Low: $329.80 on 2025-02-15

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Karuna Therapeutics, Inc. Common Stock (KRTX) is currently AltRank #1,225 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] +258
[--] Month: [-----] +175
[--] Months: [-----] +155
[--] Year: [-----] [----]
1-Year High: [-----] on 2026-01-30
1-Year Low: [--] on 2025-07-06

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +27
[--] Month: [--] +17
[--] Months: [--] +2
[--] Year: [--] +12
1-Year High: [--] on 2025-03-03
1-Year Low: [--] on 2025-06-07

Engagements: [------] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [-----]
[--] Week: [------] +64%
[--] Month: [------] -17%
[--] Months: [-------] -25%
[--] Year: [---------] -44%
1-Year High: [------] on 2025-08-12
1-Year Low: [---] on 2025-12-07

Engagements by network (24h): Reddit: [--] X: [------] News: [--] YouTube: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] -16%
[--] Month: [---] +44%
[--] Months: [---] -5.30%
[--] Year: [---] -41%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-12-07

Mentions by network (24h): Reddit: [--] X: [--] News: [--] YouTube: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Karuna Therapeutics, Inc. Common Stock (KRTX) in the last [--] hours which is up 38% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] -27%
[--] Month: [--] +56%
[--] Months: [---] -22%
[--] Year: [---] -32%
1-Year High: [--] on 2025-06-28
1-Year Low: [--] on 2025-12-15

The most influential creators that mention Karuna Therapeutics, Inc. Common Stock in the last [--] hours

Creator Rank Followers Posts Engagements
@doepke_michel [--] [-----] [--] [---]
@ParadiseTraderr [--] [---] [--] [--]
@SMALLCAPSAXIS [--] [---] [--] [--]

View More

Sentiment: 100%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 96%
[--] Week: 100% no change
[--] Month: 93% -7%
[--] Months: 93% -7%
[--] Year: 93% -7%
1-Year High: 100% on 2025-02-15
1-Year Low: 33% on 2025-04-23

Most Supportive Themes:

  • Portfolio Mentions: (75%) Karuna Therapeutics, Inc. Common Stock (KRTX) is frequently included in investor portfolios and watchlist updates, indicating its relevance in investment strategies.
  • Biotech and Healthcare Focus: (25%) Discussions surrounding KRTX are concentrated within the biotechnology and healthcare sectors, highlighting its specific industry relevance.

Most Critical Themes:

Social Dominance: 0.00186%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00186%
Daily Average: 0.00264%
[--] Week: 0.00188% +0.00118%
[--] Month: 0.0017% -0.00030000000000000014%
[--] Months: 0.0017% -0.0014%
[--] Year: 0.0017% -0.0017%
1-Year High: 0.013% on 2025-02-19
1-Year Low: 0.0004% on 2025-12-13

Market Dominance: 0.014%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.014%
Daily Average: 0%
1-Year High: 0.02% on 2025-04-08
1-Year Low: 0.014% on 2026-02-02

Top Karuna Therapeutics, Inc. Common Stock Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"LT position into [----] Part [--] # [--] Portfolio Pick Buyouts $RNA $NARI $BPMC $MYOV $IMGN $KRTX $HZNP $PRVB $ISEE $BLU $CTIC $FSTX $ICVX $LVGO $STML $JUNO $CMRX $RLYP $ITCI $KVUE Tech positions in order- $AMZN $TSLA $SOFI $COIN $GOOG $NVDA $AMD $RBRK $META $NFLX $UBER $MSFT $AVGO $ZS $MELI $IREN $NBIS Top Biotech positions: $VKTX $CYTK $BBIO $TMDX $MDGL $HROW $SLNO $IMNM $GPCR $OCUL $CRVS https://twitter.com/i/web/status/2002067407834374356 https://twitter.com/i/web/status/2002067407834374356"
X Link @Pharmdca 2025-12-19T17:24Z 108.6K followers, 56.1K engagements

"Bristol-Myers Squibb $BMY compra Karuna Therapeutics $KRTX por 14B$ esta empresa tiene un medicamento que est apunto de salir al mercado KarXT que sirve para tratar a pacientes con esquizofrenia. Parece que las grandes farmas ven con buenos ojos el crecimiento futuro de los medicamentos relacionados con la neurologa para tratar enfermedades como el prkinson o la propia esquizofrenia ya que la compra de Cerevel Therapeutics por parte de $ABBV de hace tan solo unas semanas busca un objetivo similar. https://twitter.com/i/web/status/1738485579422011854"
X Link @ProfesorDiv 2023-12-23T09:03Z 32.6K followers, 21.2K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Karuna Therapeutics, Inc. Common Stock (KRTX)
/topic/$krtx